David Einhorn - DME Capital Management
Holding/activity history for Roivant Sciences Ltd. (ROIV)
← All ROIV superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 2,152,669 | 1.87 | Add 4.03% | 0.07 | $20.78–30.33 · VW $25.87i | $59,628,931 | SEC |
| 2025 Q4 | 2,069,309 | 1.58 | Reduce 9.06% | 0.12 | $15.25–23.47 · VW $20.09i | $44,904,005 | SEC |
| 2025 Q3 | 2,275,529 | 1.35 | Reduce 50.00% | 1.11 | $10.70–16.19 · VW $13.10i | $34,428,754 | SEC |
| 2025 Q2 | 4,551,057 | 2.21 | Reduce 16.36% | 0.45 | $8.73–11.81 · VW $10.90i | $51,290,412 | SEC |
| 2025 Q1 | 5,441,167 | 2.78 | Add 3.23% | 0.09 | $9.42–11.81 · VW $10.64i | $54,901,375 | SEC |
| 2024 Q4 | 5,271,067 | 3.21 | Reduce 0.70% | 0.02 | $11.05–12.94 · VW $11.88i | $62,356,723 | SEC |
| 2024 Q3 | 5,308,040 | 2.55 | Add 10.33% | 0.24 | $10.00–13.06 · VW $11.55i | $61,254,781 | SEC |
| 2024 Q2 | 4,810,960 | 2.49 | Add 14.81% | 0.32 | $10.15–11.80 · VW $10.93i | $50,851,847 | SEC |
| 2024 Q1 | 4,190,490 | 2.02 | Buy | 2.02 | $9.69–12.00 · VW $10.70i | $44,167,765 | SEC |
Price snapshot:
Current price$34.51
Avg. buy price$11.28
+/- since buy205.90%
52-week low$10.90
52-week high$37.00